The Xpert BCR-ABL Ultra test results showed that 20 (87%) of the new CML patients had > 55% (above the upper LoQ), which indicated that BCR::ABL1 L fusion was detected at a level > 55% (IS). Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.